BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty upgraded Chemours (NYSE:CC) from Market Perform to Outperform and increased the price target from $19 to $34, indicating a positive outlook on the company's stock.
April 09, 2024 | 9:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chemours was upgraded by BMO Capital from Market Perform to Outperform with a price target increase from $19 to $34, suggesting a strong bullish outlook.
The upgrade by BMO Capital from Market Perform to Outperform, along with a significant increase in the price target, indicates a strong confidence in Chemours' future performance. This is likely to positively influence investor sentiment and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100